Mr. Terry Booth reports

AURORA CANNABIS BROADENS SENIOR LEADERSHIP TEAM

Aurora Cannabis Inc. has promoted, effective immediately, Darren Karasiuk, formerly executive vice-president, adult usage, global, to chief commercial officer. Additionally, the company has promoted, effective immediately, Jill Swainson, previously senior vice-president, legal affairs, to chief legal officer and corporate secretary of the company.

"These appointments reflect the commitment we've made to continuously strengthen our leadership team as we scale up our organization while recognizing the tremendous achievements of Jill and Darren since joining our company," said Terry Booth, chief executive officer of Aurora. "We identified early on that Darren was instrumental in the success that MedReleaf, and now Aurora, has had in the development of well-respected brands which have resonated strongly within both our medical and domestic consumer markets. His success to date has been an invaluable asset to Aurora in developing alignment within our organization to continue driving sustainable business growth.

"Jill has worked with our senior leadership team since Aurora was formed, leveraging her extensive experience and legal acumen which has been critical in successfully executing our business strategy. Throughout her tenure here, she has demonstrated the highest standard of due care in her ongoing commitment to achieving Aurora's goals and I'm pleased to recognize her hard work and numerous accomplishments with this promotion."

Chief commercial officer

Mr. Karasiuk joined the company through the acquisition of MedReleaf and has been instrumental in executing Aurora's successful launch into the Canadian consumer market, achieving strong brand recognition of the company's key consumer brands, Aurora, AltaVie and San Rafael '71. In his new role, Mr. Karasiuk will be responsible for the company's commercial strategy, including the development of an aligned organization to drive sustainable business growth. The role includes oversight of key customer facing functions including marketing, sales, insights and analytics, as well as customer service -- and strategic linkages with product development and partnerships. At MedReleaf, Mr. Karasiuk served as VP, strategy, and later SVP and general manager, recreational market. Prior to joining MedReleaf, Mr. Karasiuk was vice-president, insights and advisory, at Deloitte.

Chief legal officer and corporate secretary

Previously, Ms. Swainson served as Aurora's senior vice-president and general counsel. In this new role, Ms. Swainson will be responsible for overseeing Aurora's in-house legal team while minimizing legal risks to Aurora by advising the company's officers and board members on any legal and regulatory issues. As corporate secretary, Ms. Swainson will be responsible for ensuring the integrity of Aurora's governance framework, compliance with statutory and regulatory requirements, and implementing decisions made by the board of directors. Prior to joining Aurora in January, 2018, as general counsel, Ms. Swainson was a partner at Brownlee LLP where she handled a variety of business law matters, including corporate, commercial, intellectual property and securities work. In addition to her general practice of business law, over the past several years she has developed an expertise in providing general counsel and advisory services to clients within the heavily regulated and increasingly complex cannabis industry.

Options and restricted share unit grant

The company has awarded officers of the company 105,000 options, pursuant to the company's stock option plan, exercisable at a price of $9.43 per common share. The options shall vest over a period of three years in equal annual instalments. Additionally, the company has granted 5,000 restricted share units, vesting over three years in annual instalments.

About Aurora Cannabis Inc.

Headquartered in Edmonton, Alta., Canada, with funded capacity in excess of 500,000 kilograms per annum and sales and operations in 23 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

We seek Safe Harbor.